Clinical Trials Browser

Interventional × Liver Diseases × sintilimab × Clear all

NCT06070636 2024-08-09

bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases